SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 1.444M
March 31, 2026 1.233M
December 31, 2025 1.076M
September 30, 2025 0.5787M
June 30, 2025 0.6679M
March 31, 2025 0.8678M
December 31, 2024 1.049M
September 30, 2024 2.435M
June 30, 2024 2.135M
March 31, 2024 2.455M
December 31, 2023 2.862M
September 30, 2023 2.984M
June 30, 2023 4.309M
March 31, 2023 4.981M
September 30, 2018 4.186M
June 30, 2018 5.272M
March 31, 2018 5.966M
December 31, 2017 6.148M
September 30, 2017 8.821M
June 30, 2017 8.633M
March 31, 2017 9.150M
December 31, 2016 10.02M
September 30, 2016 10.05M
June 30, 2016 9.883M
March 31, 2016 8.997M
Date Value
December 31, 2015 7.144M
September 30, 2015 5.248M
June 30, 2015 3.562M
March 31, 2015 2.582M
December 31, 2014 2.434M
September 30, 2014 2.523M
June 30, 2014 2.273M
March 31, 2014 1.951M
December 31, 2013 1.798M
September 30, 2013 1.402M
June 30, 2013 1.655M
March 31, 2013 1.879M
December 31, 2012 2.015M
September 30, 2012 8.308M
June 30, 2012 7.998M
March 31, 2012 7.691M
December 31, 2011 7.465M
September 30, 2011 1.391M
June 30, 2011 1.151M
March 31, 2011 0.8919M
December 31, 2010 0.735M
September 30, 2010 0.0133M
June 30, 2010 0.014M
March 31, 2010 0.0135M
December 31, 2009 0.0187M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Quest Diagnostics, Inc. 2.038B
Labcorp Holdings, Inc. 2.219B
OPKO Health, Inc. 205.85M
Psychemedics Corp. --
NeoGenomics, Inc. 359.09M